PRODUCTS
SERVICES
COMPANY
CONTACT
FAQ
Search
Dictionary
Mobile
Login
Login/Nickname:
Password:
Remember login
Login
Send password reminder...
Rowan T Chlebowski Selected Research
Hormones
07/2008
Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk.
11/2007
Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
09/2006
Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.
03/2006
Obesity, hormone therapy, estrogen metabolism and risk of postmenopausal breast cancer.
02/2006
Coronary heart disease and stroke with aromatase inhibitor, tamoxifen, and menopausal hormone therapy use.
01/2005
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.
01/2005
Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidence.
02/2004
Menopausal hormone therapy after breast cancer.
12/2003
Estrogen deficiency symptom management in breast cancer survivors in the changing context of menopausal hormone therapy.
08/2002
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: status report 2002.
Articles by Research Topic
Disease
24
Breast Neoplasms (Breast Cancer)
09/2008 - 08/2002
3
Colorectal Neoplasms (Colorectal Cancer)
02/2006 - 03/2004
2
Breast Diseases (Breast Disease)
09/2008 - 04/2008
1
Neoplasms (Cancer)
10/2007
1
Obesity
03/2006
1
Cardiovascular Diseases (Cardiovascular Disease)
02/2006
1
Coronary Disease (Coronary Heart Disease)
02/2006
1
Stroke (Strokes)
02/2006
Drug/Important Bio-Agent (IBA)
10
Hormones
IBA
07/2008 - 08/2002
9
Estrogens (Estrogen)
FDA Link
09/2008 - 06/2003
5
Dietary Fats (Ghee)
IBA
10/2007 - 02/2006
4
Tamoxifen
FDA Link
Generic
04/2006 - 08/2002
3
Aromatase Inhibitors
IBA
08/2006 - 08/2002
2
Conjugated (USP) Estrogens (Premarin)
FDA Link
06/2008 - 04/2006
2
Aromatase (CYP19)
IBA
02/2006 - 08/2002
1
Cytochrome P-450 CYP2D6 (CYP2D6)
IBA
09/2008
1
Selective Estrogen Receptor Modulators (SERM)
IBA
07/2008
1
letrozole (Femara)
FDA Link
04/2006
1
Calcium
IBA
02/2006
1
Vitamin D
FDA Link
Generic
02/2006
1
Progestins (Progestagens)
IBA
04/2005
1
Insulin (Novolin)
FDA Link
11/2004
1
Diphosphonates
IBA
11/2003
1
Raloxifene (Evista)
FDA Link
08/2002
Therapy/Procedure
1
Hysterectomy
04/2006